ON HELIX 2020

THIRD PARTY

ON HELIX 2020


On-demand

Alejandra Solache discusses how sustainable, validated reagents can accelerate the development of diagnostics and therapeutics.

Learn more

Cell Cycle Club – PACE

WEBINAR

Cell Cycle Club – PACE


On-demand

Professor Sir David Lane is our keynote speaker at our next Cell Cycle Club

View webinar

Autophagy and Neurodegeneration – PACE

WEBINAR

Autophagy and Neurodegeneration – PACE


On-demand

Join Prof David Rubinsztein, as he talks us through the association between autophagy and neurodegeneration.

View webinar

Epigenetics – From Bench to Clinic – PACE

ABCAM CONFERENCES

Epigenetics – From Bench to Clinic – PACE


November

Join us for live talks on epitranscriptomics, histones, DNA modifications and polycomb.

Learn more

Spotlight on Neuroscience: Explore new ways to light up your research – PACE

ABCAM CONFERENCES

Spotlight on Neuroscience: Explore new ways to light up your research – PACE


On-demand

Dynamic talks and discussions with key leaders in the field of adult neurogenesis, brain development and repair, and neuroepigenetics.

Learn more

Abcam’s new CRISPR-Cas9 cell lines for target identification, validation and pathway discovery

Cambridge, UK, 30th January 2020 – Abcam’s new CRISPR-Cas9 knockout (KO) cell lines provide reproducible, single gene KOs that support the interrogation of the relationship between genotype and phenotype.

Obtaining high-quality KO cell lines and lysates that match specific experimental requirements can be technically challenging and time consuming, requiring months for transfection, clone isolation and screening work. Having a reliable, ready-to-use source of KO cell lines allows researchers to confidently progress target identification and validation without the need to first establish a KO cell line.

Abcam’s newly-launched collection provides the global scientific community with a wide range of KOs in commonly used immortalized cancer cell lines such as Hela and HEK293T. With an ever-expanding range of new targets and parental cell lines, selection and ordering is as easy as buying a reagent.

All KO cell lines are Sanger sequenced to confirm knockout, and many have additional Western blot data included. A wild-type positive control cell line is also available.

Abcam’s KO cell lines deliver:

  • Immediate access to pre-validated CRISPR-Cas9-engineered KO cell lines derived from Hela and HEK293T
  • Supports target identification, validation and pathway discovery, antibody screening and validation, compound hit identification and validation as well as disease model development
  • No in-house CRISPR-Cas9 or molecular biology expertise required, saving >3 months of KO production work